NEWS

Informacoes sobre medicamentos e guias de tratamento

Informacoes sobre medicamentos, indicacoes, dosagem e seguranca ligadas aos produtos atualmente disponiveis.

July 17, 2026

Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 37, Status: Authorised

Xeljanz is a medicine used to treat: Xeljanz contains the active substance tofacitinib.

July 16, 2026

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 33, Status: Authorised

Извиняваме се за неудобството.